Clinical Trials Directory

Trials / Unknown

UnknownNCT03411954

Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients

Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients:an Open, Prospective,Non-randomized Phase III Clinical Trial

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Zhejiang Cancer Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, non-randomized phase III study observing the cognitive function changes with conformal hippocampus avoidance during intensity modulated radiotherapy for T4 nasopharyngeal carcinoma patients.

Detailed description

All patients received intensity modulated radiotherapy or Tomotherapy with or without chemotherapy. Before radiotherapy, the patients will receive brain MRI scanning and the brain MRI images will be fused with the head and neck CT scan images. The investigators develop the treatment plan with hippocampus avoidance. Cognitive function are evaluated before,during and after radiotherapy. Dose-volume Histograms are got to analyze the associated factors.

Conditions

Timeline

Start date
2018-01-01
Primary completion
2021-02-01
Completion
2022-03-01
First posted
2018-01-26
Last updated
2018-01-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03411954. Inclusion in this directory is not an endorsement.